Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.

Weinbergová O, Metelka R, Vymetal J, Konecný K, Kosatíková Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004 Jul;148(1):69-73.

2.

Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.

Rysavá R, Tesar V, Merta M; Czech Group for the Study of Glomerulonephritis..

Blood Press Monit. 2005 Aug;10(4):207-13.

PMID:
16077267
4.
7.

Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.

Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.

Am J Hypertens. 2008 Dec;21(12):1330-6. doi: 10.1038/ajh.2008.297. Epub 2008 Nov 6.

PMID:
18989258
8.

Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.

Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.

Eur Rev Med Pharmacol Sci. 2012 Apr;16(4):491-8.

PMID:
22696876
9.
10.

Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.

Sharma AM, Hollander A, Köster J; Efficacy and Safety in Patients with Renal Impairment.; treated with Telmisartan (ESPRIT) Study Group..

Clin Nephrol. 2005 Apr;63(4):250-7.

PMID:
15847251
11.

Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.

Williams B, Lacourcière Y, Schumacher H, Gosse P, Neutel JM.

J Hum Hypertens. 2009 Sep;23(9):610-9. doi: 10.1038/jhh.2009.4. Epub 2009 Feb 19.

PMID:
19225530
12.

Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients.

Cupisti A, Rizza GM, D'Alessandro C, Morelli E, Barsotti G.

Biomed Pharmacother. 2003 May-Jun;57(3-4):169-72.

PMID:
12818479
14.
15.

Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.

Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C; VIVALDI investigators..

Nephrol Dial Transplant. 2008 Oct;23(10):3174-83. doi: 10.1093/ndt/gfn230. Epub 2008 May 1.

PMID:
18450829
16.

Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.

Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P.

J Hum Hypertens. 2006 Mar;20(3):177-85.

PMID:
16306998
17.

Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.

Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, Dejima T, Yanagi M, Azuma K, Umemura S.

Hypertens Res. 2009 Nov;32(11):950-5. doi: 10.1038/hr.2009.131. Epub 2009 Aug 28.

PMID:
19713965
18.

Sustained antihypertensive activity of telmisartan compared with valsartan.

Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.

Blood Press Monit. 2004 Aug;9(4):203-10.

PMID:
15311147
19.

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.

Freytag F, Schelling A, Meinicke T, Deichsel G; Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group..

Clin Ther. 2001 Jan;23(1):108-23.

PMID:
11219471
20.

Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy.

Anantharaman R, Bhansali A, Bhadada SK, Kohli HS, Dutta P, Walia R, Jayaprakash P, Upreti V.

Indian J Med Res. 2010 Jul;132:42-7.

Supplemental Content

Support Center